Showing results (1081-1090 of 1,504) with videos related to
Sort By:
Pageof 151
Familial Cancer|April 29, 2023
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literatureKetty Hu-Heimgartner, Noémie Lang, Aurélie Ayme, et al.Familial Cancer|January 15, 2014
The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancerM Casper, M Acalovschi, F Lammert, et al.Familial Cancer|August 12, 2025
SMARCB1-related schwannomatosis and other SMARCB1-associated phenotypes: clinical spectrum and molecular pathogenesisHildegard Kehrer-Sawatzki, David N CooperFamilial Cancer|November 10, 2025
The germline POLD1 c.1420 C > A (p.Leu474Ile) variant segregates with endometrial cancer, colorectal cancer and colonic polyps demonstrating hypermutation and defective POLD1 mutational signaturesDaniel D Buchanan, Peter Georgeson, Romy Walker, et al.Familial Cancer|September 10, 2025
Navigating disclosure in new romantic partnerships as an adolescent or young adult with Li-Fraumeni syndromeCamella J Rising, Chloe O Huelsnitz, Rowan Forbes Shepherd, et al.Familial Cancer|June 20, 2025
A coordinated multidisciplinary model of care is needed for child and family centered care in pediatric genetic cancer risk services: a scoping reviewAndrew M Grant, Natalie Taylor, Jane Maguire, et al.Familial Cancer|June 1, 2025
Redefining familial adenomatous polyposis: competition, cooperation, and the path to monoclonalitySylvain Ferrandon, Matthew F Kalady, Sanne M van NeervenFamilial Cancer|March 17, 2024
Progress report: Peutz-Jeghers syndromeAnne Marie Jelsig, John Gásdal Karstensen, Thomas V Overeem HansenFamilial Cancer|March 29, 2024
Clinician perspectives on policy approaches to genetic risk disclosure in familiesAmicia Phillips, Danya F Vears, Ine Van Hoyweghen, et al.Pageof 151